Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,616,835
-
Share change
-
+2,590,158
-
Total reported value
-
$553,805,868
-
Put/Call ratio
-
117%
-
Price per share
-
$23.45
-
Number of holders
-
65
-
Value change
-
+$59,301,869
-
Number of buys
-
37
-
Number of sells
-
35
Institutional Holders of AKCEA THERAPEUTICS INC - COM (AKCA) as of Q2 2019
As of 30 Jun 2019,
AKCEA THERAPEUTICS INC - COM (AKCA) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,616,835 shares.
The largest 10 holders included
FMR LLC, Bellevue Group AG, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and OZ MANAGEMENT LP.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.